SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-188878
Filing Date
2021-06-11
Accepted
2021-06-11 16:16:00
Documents
6
Effectiveness Date
2021-06-11

Document Format Files

Seq Description Document Type Size
1 S-8 d148316ds8.htm S-8 70269
2 EX-5.1 d148316dex51.htm EX-5.1 41312
3 EX-23.1 d148316dex231.htm EX-23.1 1518
4 EX-23.2 d148316dex232.htm EX-23.2 1583
5 EX-23.3 d148316dex233.htm EX-23.3 1465
6 GRAPHIC g148316dsp1.jpg GRAPHIC 7223
  Complete submission text file 0001193125-21-188878.txt   127441
Mailing Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH
Business Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH 44 (0)7767 003904
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-257027 | Film No.: 211011465
SIC: 2834 Pharmaceutical Preparations